Studies

Exercise and Epicatechin

Exercise and Epicatechin

A study of sedentary men and women aged 18 to 45 years with no known chronic diseases divided into two groups: one received a dietary supplement and the other a placebo. Both groups engaged in moderate exercise (≥150 min/week) for three months.

Preliminary results in patients with COVID-19

Persistent fatigue is one of the symptoms that can last weeks or months after the initial SARS-CoV-2 infection. There is scientific evidence that the flavonoids can modulate the molecular pathways involved in the development of mitochondrial myopathy. To determine whether an epicatechin-enriched supplement (EC) can improve plasma markers of inflammation and fatigue in long COVID-19 patients, we conducted a randomized, double-blind, clinical trial. The study included 46 subjects (mean age 52 years) allocated into EC or placebo, and were instructed to consume 2 capsules /day for up to 90 days. A comprehensive set of endpoints were assessed, which included mean

(−)-Epicatechin-Enriched Extract from Camellia sinensis Improves Regulation of Muscle Mass and Function: Results from a Randomized Controlled Trial

Loss of skeletal muscle mass and function with age represents an important source of frailty and functional decline in the elderly. Antioxidants from botanical extracts have been shown to enhance the development, mass, and strength of skeletal muscle by influencing age-related cellular and molecular processes. Tannase-treated green tea extract contains high levels of the antioxidants (−)-epicatechin (EC) and gallic acid that may have therapeutic benefits for age-related muscle decline. The aim of this study was to investigate the effect of tannase-treated green tea extract on various muscle-related parameters, without concomitant exercise, in a single-center, randomized, double-blind, placebo-controlled study. Administration of

(-)-Epicatechin-induced calcium independent eNOS activation: roles of HSP90 and AKT

Cardiovascular disease (CVD) is a leading determinant of mortality and morbidity in the world. Epidemiologic studies suggest that flavonoid intake plays a role in the prevention of CVD. Consumption of cocoa products rich in flavonoids lowers blood pressure and improves endothelial function in healthy subjects as well as in subjects with vascular dysfunction such as smokers and diabetics. The vascular actions of cocoa follow the stimulation of nitric oxide (NO). These actions can be reproduced by the administration of the cocoa flavanol (-)-epicatechin (EPI). Previously, using human endothelial cells cultured in calcium-free media, we documented EPI effects on eNOS independently

Popular

Tags